As combined inhibition of Akt and mTOR by perfosine and temsirolimus inhibited murine glioblastoma growth no matter PTEN status, a phase I/II trial in recurrent high-grade gliomais ongoing (NCT01051557) [75, 76]. The gene discussed is PTEN; the disease is glioblastoma.